By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Trevena, Inc. 

Berwyn  Pennsylvania    U.S.A.
Phone: n/a Fax: n/a



Drug Discovery

Company News
Trevena, Inc. (TRVN) Announces Positive Top-Line Results From Phase 2a/b Study Of TRV130 In Acute Postoperative Pain 11/18/2014 5:58:49 AM
Trevena, Inc. (TRVN) Reports Third Quarter 2014 Financial Results And Provides A Corporate Update 11/11/2014 9:23:36 AM
Trevena, Inc. (TRVN) Announces Early Completion Of Enrollment Of Phase 2a/B Study Of TRV130 In Postoperative Pain 10/8/2014 10:06:57 AM
Trevena, Inc. (TRVN) Enters Into $35 Million Tranched Term Loan Credit Facility 9/22/2014 8:40:09 AM
Trevena, Inc. (TRVN) Appoints Adam M. Koppel To The Board Of Directors 9/18/2014 10:54:35 AM
Trevena, Inc. (TRVN) Granted Key U.S. Composition Of Matter Patent For TRV130 9/16/2014 9:19:32 AM
Trevena, Inc. (TRVN) Reports Second Quarter 2014 Financial Results 8/12/2014 8:46:05 AM
Trevena, Inc. (TRVN) CEO To Present At The Canaccord Genuity 34th Annual Growth Conference 8/8/2014 9:17:09 AM
Trevena, Inc. (TRVN) Initiates Phase 1 Multiple Ascending Dose Study Of TRV734 For Acute And Chronic Pain 8/6/2014 9:41:54 AM
Trevena, Inc. (TRVN) Granted Key U.S. Method Of Use Patent For TRV027 8/5/2014 10:08:09 AM